| Age (year) |
|
|
51±14.6 |
| Sex |
|
|
|
| Male |
10 |
23.8 |
|
| Female |
32 |
76.2 |
|
| Body mass index |
|
|
26±2.5 |
| Ejection fraction (%) |
|
|
32±14.7 |
| SAPS-II |
|
|
48±13.7 |
| SOFA-ICU |
|
|
11±2.7 |
| Mechanical circulatory support |
|
|
|
| LVAD (%) |
17 |
42.5 |
|
| LVAD + ECMO (%) |
11 |
26.2 |
|
| ECMO (%) |
14 |
33.3 |
|
| LVAD indications* |
|
|
|
| Dilated cardiomyopathy (%) |
9 |
32.1 |
|
| Ischemic cardiomyopathy (%) |
8 |
28.6 |
|
| Postcardiotomy syndrome (%) |
11 |
39.3 |
|
| VA-ECMO indicationst |
|
|
|
| Acute myocardial infarction (%) |
5 |
20 |
|
| Postoperative lung transplantation (%) |
2 |
8 |
|
| Dilate cardiomyopathy (%) |
2 |
8 |
|
| Ischemic cardiomyopathy (%) |
3 |
12 |
|
| Postcardiotomy syndrome (%) |
13 |
52 |
|
| LVAD + ECMO indications‡ |
|
|
|
| Dilated cardiomyopathy (%) |
2 |
18.2 |
|
| Ischemic cardiomyopathy (%) |
3 |
27.3 |
|
| Postcardiotomy syndrome (%) |
6 |
54.5 |
|
| SD: Standard deviation; SAPS-II: Simplified Acute Physiology Score-II; SOFA: Sequential Organ Failure Assessment; ICU: Intensive care unit; LVAD: Left ventricular assist device; ECMO: Extracorporeal membrane oxygenation; VA: Veno-arterial; * 28 patients with LVAD (Only LVAD, LVAD + ECMO); † 25 patients with ECMO (Only ECMO, LVAD + ECMO); ‡ 11 patients with LVAD + ECMO; SOFA (min: 4; max:24); SAPS-II (min:0; max:163). |
